Best General Drug Manufacturer Stocks to Buy Now (2025)Top general drug manufacturer stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best general drug manufacturer stocks to buy now. Learn More.
Industry: Drug Manufacturers - Gene...
A
General Drug Manufacturers is Zen Rated A and is the 5th ranked industry out of 145 stock market industries
Learn how the Zen Ratings work| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BMY | BRISTOL MYERS SQUIBB CO | $94.60B | $46.47 | $40.50 | -12.85% | Sell | 2 | -3.55% | 25.52% | 61.36% | 11.75% | |||
| LLY | ELI LILLY & CO | $875.25B | $925.81 | $916.38 | -1.02% | Strong Buy | 8 | 13.44% | 22.53% | 174.93% | 36.21% | |||
| GSK | GSK PLC | $94.17B | $46.69 | N/A | N/A | N/A | N/A | -5.16% | -17.69% | 42.83% | 11.27% | |||
| AMRN | AMARIN CORP PLC | $318.34M | $15.31 | $12.00 | -21.62% | Strong Sell | 1 | -4.16% | N/A | 50.84% | 35.36% | |||
| ABBV | ABBVIE INC | $383.12B | $216.77 | $254.75 | 17.52% | Strong Buy | 12 | 6.88% | 131.71% | -1,193.79% | 23.56% | |||
| GRFS | GRIFOLS SA | $5.93B | $8.63 | $10.30 | 19.35% | Hold | 1 | 2.33% | 69.33% | 16.33% | 4.49% | |||
| JNJ | JOHNSON & JOHNSON | $448.13B | $186.00 | $196.60 | 5.70% | Buy | 15 | 4.31% | 6.04% | 40.02% | 16.45% | |||
| GILD | GILEAD SCIENCES INC | $152.10B | $122.58 | $131.67 | 7.41% | Strong Buy | 9 | 3.64% | 23.25% | 64.56% | 22.79% | |||
| AZN | ASTRAZENECA PLC | $251.57B | $81.15 | N/A | N/A | N/A | N/A | 5.94% | 64.13% | 45.94% | 18.28% | |||
| SNY | SANOFI | $123.79B | $49.00 | $58.00 | 18.37% | Strong Buy | 1 | 0.36% | 28.31% | 15.32% | 8.58% | |||
| SCLX | SCILEX HOLDING CO | $128.47M | $18.47 | N/A | N/A | N/A | N/A | 127.94% | N/A | -27.10% | 80.56% | |||
| MRK | MERCK & CO INC | $210.79B | $84.39 | $93.75 | 11.09% | Hold | 4 | 4.45% | 17.07% | 56.82% | 23.69% | |||
| NVS | NOVARTIS AG | $241.71B | $125.50 | $118.00 | -5.98% | Strong Sell | 1 | 2.14% | 11.37% | 50.34% | 20.80% | |||
| AMGN | AMGEN INC | $172.24B | $319.86 | $304.78 | -4.72% | Hold | 9 | 1.83% | 20.50% | 130.83% | 13.96% | |||
| PFE | PFIZER INC | $139.93B | $24.61 | $29.33 | 19.19% | Hold | 3 | -0.54% | 22.60% | 16.95% | 7.54% | |||
| BIIB | BIOGEN INC | $22.51B | $153.43 | $160.33 | 4.50% | Buy | 9 | -2.44% | 13.75% | 13.51% | 8.42% | |||
| OGN | ORGANON & CO | $1.66B | $6.38 | $18.00 | 182.13% | Strong Buy | 1 | 0.90% | 16.00% | 160.12% | 8.69% | |||
| MIRA | MIRA PHARMACEUTICALS INC | $29.18M | $1.53 | N/A | N/A | N/A | N/A | N/A | N/A | -324.26% | -212.80% | |||
| MDCX | MEDICUS PHARMA LTD | $40.98M | $2.30 | $23.50 | 921.74% | Strong Buy | 2 | N/A | N/A | -83.91% | -22.84% | |||
| NSRX | NASUS PHARMA LTD | N/A | $7.55 | $22.00 | 191.39% | Strong Buy | 1 | N/A | N/A | N/A | N/A |
General Drug Manufacturer Stocks FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.